Hydroxychloroquine and Chloroquine Retinopathy (eBook)
XV, 291 Seiten
Springer New York (Verlag)
978-1-4939-0597-3 (ISBN)
Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening, ancillary testing, to whom and why the drugs are prescribed and dosing considerations. Additionally, the book addresses practice management considerations, including coding, reimbursement and equipment costs, and the medico-legal responsibilities of the rheumatologist and of the ophthalmologist. Guidelines for the management of hydroxychloroquine and chloroquine vary around the world and differences between the guidelines of the United Kingdom, the United States, and other countries are identified. The book concludes with a collection of case examples illustrating common clinical scenarios and their management. This book is a 'must-have' resource for physicians who use these drugs.
David J. Browning, MD, PhD is an ophthalmologist with a PhD in pharmacology and is on the editorial board of the American Journal of Ophthalmology. He has published two books with Springer, Diabetic Retinopathy and Retinal Vein Occlusions.
Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening, ancillary testing, to whom and why the drugs are prescribed and dosing considerations. Additionally, the book addresses practice management considerations, including coding, reimbursement and equipment costs, and the medico-legal responsibilities of the rheumatologist and of the ophthalmologist. Guidelines for the management of hydroxychloroquine and chloroquine vary around the world and differences between the guidelines of the United Kingdom, the United States, and other countries are identified. The book concludes with a collection of case examples illustrating common clinical scenarios and their management. This book is a "e;must-have"e; resource for physicians who use these drugs.
David J. Browning, MD, PhD is an ophthalmologist with a PhD in pharmacology and is on the editorial board of the American Journal of Ophthalmology. He has published two books with Springer, Diabetic Retinopathy and Retinal Vein Occlusions.
1. Preclinical Foundations: Relevant Anatomy and Physiology.- 2. Pharmacology of Chloroquine and Hydroxychloroquine.- 3. Toxicology of Hydroxychloroquine and Chloroquine and the Pathology of the Retinopathy They Cause.- 4. Definitions of Hydroxychloroquine and Chloroquine Retinopathy.- 5. Epidemiology of Hydroxychloroquine and Chloroquine Retinopathy.- 6. Natural History of Hydroxychloroquine and Chloroquine Retinopathy.- 7. Risk Factors for Hydroxychloroquine and Chloroquine Retinopathy.- 8. Ancillary Testing in Screening for Hydroxychloroquine and Chloroquine Retinopathy.- 9. Screening for Hydroxychloroquine and Chloroquine Retinopathy.- 10. Clinical Examples in Managing Patients Taking 4-Aminoquinolines.
Erscheint lt. Verlag | 9.5.2014 |
---|---|
Zusatzinfo | XV, 291 p. 113 illus. in color. |
Verlagsort | New York |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Augenheilkunde |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie | |
Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Schlagworte | Chloroquine • Hydroxychloroquine • Ocular Toxicity Screening • Ophthalmology • Retinal Toxicity • Toxicology |
ISBN-10 | 1-4939-0597-X / 149390597X |
ISBN-13 | 978-1-4939-0597-3 / 9781493905973 |
Haben Sie eine Frage zum Produkt? |
Größe: 18,3 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich